| The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer P Venkatesan, N Puvvada, R Dash, BNP Kumar, D Sarkar, B Azab, ... Biomaterials 32 (15), 3794-3806, 2011 | 294 | 2011 |
| Targeting Mcl-1 for the therapy of cancer BA Quinn, R Dash, B Azab, S Sarkar, SK Das, S Kumar, RA Oyesanya, ... Expert opinion on investigational drugs 20 (10), 1397-1411, 2011 | 255 | 2011 |
| Therapy-induced senescence: an “old” friend becomes the enemy T Saleh, S Bloukh, VJ Carpenter, E Alwohoush, J Bakeer, S Darwish, ... Cancers 12 (4), 822, 2020 | 240 | 2020 |
| Human polynucleotide phosphorylase selectively and preferentially degrades microRNA-221 in human melanoma cells SK Das, UK Sokhi, SK Bhutia, B Azab, Z Su, D Sarkar, PB Fisher Proceedings of the National Academy of Sciences 107 (26), 11948-11953, 2010 | 149 | 2010 |
| Mechanism of autophagy to apoptosis switch triggered in prostate cancer cells by antitumor cytokine melanoma differentiation-associated gene 7/interleukin-24 SK Bhutia, R Dash, SK Das, B Azab, Z Su, SG Lee, S Grant, A Yacoub, ... Cancer research 70 (9), 3667-3676, 2010 | 149 | 2010 |
| Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24–mediated toxicity R Dash, B Azab, BA Quinn, X Shen, XY Wang, SK Das, M Rahmani, J Wei, ... Proceedings of the National Academy of Sciences 108 (21), 8785-8790, 2011 | 146 | 2011 |
| Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer S Rajput, BNP Kumar, S Sarkar, S Das, B Azab, PK Santhekadur, SK Das, ... PloS one 8 (4), e61342, 2013 | 144 | 2013 |
| mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity R Dash, SK Bhutia, B Azab, Z Su, BA Quinn, TP Kegelmen, SK Das, K Kim, ... Cytokine & growth factor reviews 21 (5), 381-391, 2010 | 136 | 2010 |
| Astrocyte elevated gene-1 induces protective autophagy SK Bhutia, TP Kegelman, SK Das, B Azab, Z Su, SG Lee, D Sarkar, ... Proceedings of the National Academy of Sciences 107 (51), 22243-22248, 2010 | 134 | 2010 |
| MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanoma SK Das, SK Bhutia, B Azab, TP Kegelman, L Peachy, PK Santhekadur, ... Cancer research 73 (2), 844-854, 2013 | 102 | 2013 |
| MDA-9/syntenin: a positive gatekeeper of melanoma metastasis SK Das, SK Bhutia, TP Kegelman, L Peachy, RA Oyesanya, S Dasgupta, ... Front Biosci 17 (1), 1-15, 2012 | 92 | 2012 |
| Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10–related cytokine R Dash, JE Richards, Z Su, SK Bhutia, B Azab, M Rahmani, ... Cancer research 70 (12), 5034-5045, 2010 | 88 | 2010 |
| Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma SK Das, SK Bhutia, UK Sokhi, B Azab, Z Su, H Boukerche, T Anwar, ... Cancer research 72 (23), 6217-6226, 2012 | 76 | 2012 |
| Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad. 5/3) improves therapeutic efficacy in low CAR prostate cancer cells R Dash, I Dmitriev, ZZ Su, SK Bhutia, B Azab, N Vozhilla, A Yacoub, ... Cancer gene therapy 17 (7), 447-456, 2010 | 70 | 2010 |
| Inhibition of AP-1 by SARI negatively regulates transformation progression mediated by CCN1 R Dash, ZZ Su, SG Lee, B Azab, H Boukerche, D Sarkar, PB Fisher Oncogene 29 (31), 4412-4423, 2010 | 63 | 2010 |
| Targeting breast cancer‐initiating/stem cells with melanoma differentiation‐associated gene‐7/interleukin‐24 SK Bhutia, SK Das, B Azab, ME Menezes, P Dent, XY Wang, D Sarkar, ... International journal of cancer 133 (11), 2726-2736, 2013 | 62 | 2013 |
| Enhanced delivery of mda‐7/IL‐24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the apogossypol derivative BI‐97C1 (Sabutoclax) improves … B Azab, R Dash, SK Das, SK Bhutia, XN Shen, BA Quinn, S Sarkar, ... Journal of cellular physiology 227 (5), 2145-2153, 2012 | 54 | 2012 |
| Pancreatic cancer combination therapy using a BH3 mimetic and a synthetic tetracycline BA Quinn, R Dash, S Sarkar, B Azab, P Bhoopathi, SK Das, L Emdad, ... Cancer research 75 (11), 2305-2315, 2015 | 48 | 2015 |
| Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic R Dash, B Azab, XN Shen, UK Sokhi, S Sarkar, Z Su, XY Wang, ... Discovery medicine 11 (56), 46, 2011 | 48 | 2011 |
| PKM2 and HIF-1α regulation in prostate cancer cell lines D Hasan, E Gamen, N Abu Tarboush, Y Ismail, O Pak, B Azab PLoS One 13 (9), e0203745, 2018 | 45 | 2018 |